Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sinopharm Group (OP: SHTDY )

12.80 -0.35 (-2.64%)
Streaming Delayed Price Updated: 3:50 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Sinopharm Group

Current Analysis: Sinopharm Group (SHTDY)
Founded in 2003, Sinopharm (SHTDY​​​​​​​) is the largest wholesaler and retailer of drugs and medical devices in China. Over the past year, Sinopharm share price fell about 7% from $13.61 to $12.67 as... 
Via Talk Markets
Current Analysis: Sinopharm Group
Sinopharm Group Co. Ltd. was founded in 2003 and listed on the Hong Kong Stock Exchange in September 2009. Over the past year, Sinopharm’s share price rose about 20% from $10.26 to $12.36 as of... 
Via Talk Markets
Week In Review: A Consortium Of China Drug Distributors Want To Acquire Poland's Neuca
China’s drug distributors are in the hunt to acquire Poland’s Neuca, a company with a 32% market share of Poland’s pharmaceutical distribution business. The consortium of China’s drug distributors may... 
Via Talk Markets
Daily Stock Analysis: Sinopharm Group
Sinopharm Group Co. Ltd.'s main business is drug distribution in mainland China, which contributes about 75% of total revenue. 
Via Talk Markets
Jim Cramer Says China's Vaccines 'Don't Work' But Xi Won't Admit It
COVID-19 cases have spiked again in China, sparking fresh lockdown measures in the nation's capital. Jim Cramer has suggested that Chinese President Xi Jinping isn't telling the whole story.  
Via Benzinga
UK Trial On Mix-Match COVID-19 Vaccines Expanded To Add Moderna, Novavax Shots
Researchers said that a U.K. study of using different Covid-19 vaccines in two-dose inoculations is now expanded to include vaccines made by Moderna Inc (NASDAQ: ... 
Via Benzinga
Exposures COVID-19
South African Variant Able To Elude Pfizer/BioNTech' Vaccine Protection, Israeli Study Shows: Report
According to a real-world data study in Israel, the coronavirus variant discovered in South Africa may dodge the protection provided by Pfizer Inc (NYSE: PFE) /... 
Via Benzinga
Exposures COVID-19
Government, Officials Defend AstraZeneca's COVID-19 Shot: CNBC
The British government and health experts in the country have come forward to defend the COVID-19 vaccine developed by AstraZeneca plc’s (NASDAQ: AZN) and... 
Via Benzinga
Exposures COVID-19
Europe's Drug Watchdog Concludes Possible Link Between AstraZeneca COVID-19 Vaccine And Blood Clots
The European Medicines Agency (EMA), after an in-depth analysis, has concluded that unusual blood clots should be listed as a “very rare side effect” of the... 
Via Benzinga
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.